BRIEF published on 07/30/2026 at 21:54, 14 days 15 hours ago Ikonisys SA Reports Increased Revenues and Developments in 2025 Revenue Growth Ikonisys SA Oncology Diagnostics ALIKO SCIENTIFIC Financial Results 2025
BRIEF published on 07/30/2026 at 21:54, 14 days 15 hours ago Ikonisys SA annonce des résultats annuels 2025 prometteurs Résultats Financiers Croissance Ikonisys Diagnostic Oncologique ALIKO SCIENTIFIC
BRIEF published on 07/30/2026 at 21:54, 14 days 15 hours ago Ikonisys SA announces promising annual results for 2025 Financial Results Growth Ikonisys ALIKO SCIENTIFIC Oncological Diagnosis
BRIEF published on 07/30/2026 at 21:54, 14 days 15 hours ago Ikonisys SA annonce une augmentation de son chiffre d'affaires et des développements en 2025 Ikonisys SA Croissance Des Revenus Résultats Financiers 2025 Diagnostic En Oncologie Aliko Scientifique
PRESS RELEASE published on 07/30/2026 at 21:49, 14 days 15 hours ago Informations privilégiées / Communiqué sur comptes, résultats Ikonisys SA publie ses résultats financiers annuels 2025. Amélioration de 32,9% de l'EBITDA à -1,14 M€. Développement de la plateforme oncologique avec brevet ACTA, Urine24 et accord Menarini Diagnostics Résultats Financiers EBITDA Ikonisys SA Développements Plateforme Oncologique
PRESS RELEASE published on 07/30/2026 at 21:49, 14 days 15 hours ago Inside Information / News release on accounts, results Aliko Scientific (Ikonisys SA) reports 52.6% increase in total revenue to €1.64 million and 32.9% improvement in EBITDA for 2025. Developments include US patent for ACTA, launch of Urine24, and agreement with Menarini Diagnostics Financial Results Revenue Increase EBITDA Improvement Oncology Diagnostics ALIKO SCIENTIFIC
BRIEF published on 07/23/2026 at 07:35, 22 days 5 hours ago Hospitex International Initiates Urine24 Feasibility Study in Uzbekistan Feasibility Study Cancer Diagnostics Hospitex International Urine24 Uzbek Oncology Institute
BRIEF published on 07/23/2026 at 07:35, 22 days 5 hours ago Hospitex International initiates a feasibility study in Uzbekistan for Urine24 Feasibility Study Hospitex International Uzbekistan Urine24 Oncological Diagnoses
BRIEF published on 07/23/2026 at 07:35, 22 days 5 hours ago Hospitex International lance une étude de faisabilité sur Urine24 en Ouzbékistan Étude De Faisabilité Hospitex International Diagnostic Du Cancer Urine24 Institut D'oncologie Ouzbek
BRIEF published on 07/23/2026 at 07:35, 22 days 5 hours ago Hospitex International initie une étude de faisabilité en Ouzbékistan pour Urine24 Étude De Faisabilité Hospitex International Ouzbékistan Diagnostics Oncologiques Urine24
Published on 08/14/2026 at 13:30, 3 minutes ago Digi Power X Reports Second Quarter 2026 Financial Results and Provides Operational Update and 2027 Outlook
Published on 08/14/2026 at 13:15, 18 minutes ago Mako Mining Reports Q2 2026 Financial Results, Including Adjusted EBITDA(1) of US$31.7 Million and EPS of US$0.16/Share
Published on 08/14/2026 at 13:10, 23 minutes ago SouthGobi Announces Second Quarter 2026 Unaudited Financial and Operating Results
Published on 08/14/2026 at 09:01, 4 hours 32 minutes ago Apex Announces Filing of Final Base Shelf Prospectus
Published on 08/14/2026 at 08:00, 5 hours 33 minutes ago Touchstone Exploration Announces Second Quarter 2026 Results and Operational Update
Published on 08/14/2026 at 13:20, 12 minutes ago Nagarro Management Board and Supervisory Board recommend the acceptance of the voluntary public takeover offer by Persistent
Published on 08/14/2026 at 12:30, 1 hour 2 minutes ago Diginex and Resulticks Sign Amended Definitive Agreement to Create a Global AI-Powered Group Spanning Customer Engagement and Trusted Sustainability Data
Published on 08/14/2026 at 12:08, 1 hour 24 minutes ago Nagarro Management Board and Supervisory Board recommend the acceptance of the voluntary public takeover offer by Persistent
Published on 08/14/2026 at 12:05, 1 hour 27 minutes ago THE GALLIPOLI CAMPAIGN REVITALIZED IN THE DIGITAL REALM
Published on 08/14/2026 at 12:00, 1 hour 32 minutes ago EQS-Adhoc: Homann Holzwerkstoffe GmbH revises its full-year forecast: Preliminary half-year figures for 2026 below the previous year’s level due to persistently high start-up losses a
Published on 08/13/2026 at 18:00, 19 hours 33 minutes ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 19 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 19 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 19 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 19 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
